CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale Director sold 17,915 shares at an average $29.06 ($520,694)
- 4 Open-market sale Chief Medical Officer sold 4,991 shares at $24.89 ($124,209)
- 4 Other disposition Director disposed of 3,374 shares (other)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
- 4 Other disposition Director disposed of 500,000 shares (other)
- 4 Open-market sale Director sold 17,915 shares at an average $25.84 ($462,976)
- 4 Other disposition Director disposed of 500,000 shares (other)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Open-market sale Director sold 3,374 shares at $23.82 ($80,369)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Grant or award Director acquired 6,405 shares (grant or award)
- 4 Open-market sale Director sold 1,687 shares at $23.82 ($40,184)
- 4 Open-market sale Director sold 14,541 shares at $20.62 ($299,835)
- 4/A Other acquisition Director acquired 102,041 shares (other)
- 4 Open-market sale Director sold 17,915 shares at an average $20.90 ($374,424)
Page 12 of 25 · 491 filings